» Articles » PMID: 34652881

A Click Chemistry Approach to Targeted DNA Crosslinking with Cis-Platinum(II)-Modified Triplex-Forming Oligonucleotides

Overview
Specialty Chemistry
Date 2021 Oct 15
PMID 34652881
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Limitations of clinical platinum(II) therapeutics include systemic toxicity and inherent resistance. Modern approaches, therefore, seek new ways to deliver active platinum(II) to discrete nucleic acid targets. In the field of antigene therapy, triplex-forming oligonucleotides (TFOs) have attracted interest for their ability to specifically recognise extended duplex DNA targets. Here, we report a click chemistry based approach that combines alkyne-modified TFOs with azide-bearing cis-platinum(II) complexes-based on cisplatin, oxaliplatin, and carboplatin motifs-to generate a library of Pt -TFO hybrids. These constructs can be assembled modularly and enable directed platinum(II) crosslinking to purine nucleobases on the target sequence under the guidance of the TFO. By covalently incorporating modifications of thiazole orange-a known DNA-intercalating fluorophore-into Pt -TFOs constructs, enhanced target binding and discrimination between target and off-target sequences was achieved.

Citing Articles

Chemoproteomic profiling unveils binding and functional diversity of endogenous proteins that interact with endogenous triplex DNA.

Xu H, Ye J, Zhang K, Hu Q, Cui T, Tong C Nat Chem. 2024; 16(11):1811-1821.

PMID: 39223307 DOI: 10.1038/s41557-024-01609-7.


Neighboring Effect-Initiated Supramolecular Nanocomplex with Sequential Infiltration as Irreversible Apoptosis Inducer for Synergetic Chemo-Immunotherapy.

Ye M, Hu J, Han L, Zhang H, Xue P, Kang Y Adv Sci (Weinh). 2024; 11(38):e2402809.

PMID: 39137339 PMC: 11481388. DOI: 10.1002/advs.202402809.


Click-Capable Phenanthriplatin Derivatives as Tools to Study Pt(II)-Induced Nucleolar Stress.

ODowd P, Guerrero A, Alley K, Pigg H, ONeill F, Meiller J ACS Chem Biol. 2024; 19(4):875-885.

PMID: 38483263 PMC: 11040607. DOI: 10.1021/acschembio.3c00607.


Thiazole orange-carboplatin triplex-forming oligonucleotide (TFO) combination probes enhance targeted DNA crosslinking.

Hennessy J, Klimkowski P, Singleton D, Gibney A, Coche M, Farrell N RSC Med Chem. 2024; 15(2):485-491.

PMID: 38389892 PMC: 10880910. DOI: 10.1039/d3md00548h.


Recent Advancements in Development and Therapeutic Applications of Genome-Targeting Triplex-Forming Oligonucleotides and Peptide Nucleic Acids.

Mikame Y, Yamayoshi A Pharmaceutics. 2023; 15(10).

PMID: 37896275 PMC: 10609763. DOI: 10.3390/pharmaceutics15102515.


References
1.
Graham M, Miller P . Inhibition of transcription by platinated triplex-forming oligonucleotides. J Biol Inorg Chem. 2012; 17(8):1197-208. DOI: 10.1007/s00775-012-0933-9. View

2.
Fox K . Targeting DNA with triplexes. Curr Med Chem. 2000; 7(1):17-37. DOI: 10.2174/0929867003375506. View

3.
Sun J, Garestier T, Helene C . Oligonucleotide directed triple helix formation. Curr Opin Struct Biol. 1996; 6(3):327-33. DOI: 10.1016/s0959-440x(96)80051-0. View

4.
Gruff E, Orgel L . An efficient, sequence-specific method for crosslinking complementary oligonucleotides using binuclear platinum complexes. Nucleic Acids Res. 1991; 19(24):6849-54. PMC: 329319. DOI: 10.1093/nar/19.24.6849. View

5.
Nielsen P . DNA analogues with nonphosphodiester backbones. Annu Rev Biophys Biomol Struct. 1995; 24:167-83. DOI: 10.1146/annurev.bb.24.060195.001123. View